Cargando…
Response Variability to Drug Testing in Two Models of Chemically Induced Colitis
The lack of knowledge regarding the pathogenesis of IBD is a challenge for the development of more effective and safer therapies. Although in vivo preclinical approaches are critical for drug testing, none of the existing models accurately reproduce human IBD. Factors that influence the intra-indivi...
Autores principales: | Suau, Roger, Garcia, Anna, Bernal, Carla, Llaves, Mariona, Schiering, Katharina, Jou-Ollé, Eva, Pertegaz, Alex, Garcia-Jaraquemada, Arce, Bartolí, Ramon, Lorén, Violeta, Vergara, Patri, Mañosa, Míriam, Domènech, Eugeni, Manyé, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094987/ https://www.ncbi.nlm.nih.gov/pubmed/37047397 http://dx.doi.org/10.3390/ijms24076424 |
Ejemplares similares
-
Interleukin-10 Enhances the Intestinal Epithelial Barrier in the Presence of Corticosteroids through p38 MAPK Activity in Caco-2 Monolayers: A Possible Mechanism for Steroid Responsiveness in Ulcerative Colitis
por: Lorén, Violeta, et al.
Publicado: (2015) -
Editorial: Postoperative management of Crohn's disease: One size does not fit all
por: Domènech, Eugeni, et al.
Publicado: (2023) -
Optimizing post-operative Crohn’s disease treatment
por: Domènech, Eugeni, et al.
Publicado: (2014) -
Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective
por: Domènech, Eugeni, et al.
Publicado: (2021) -
Treatment Adherence and Clinical Outcomes of Patients with Inflammatory Bowel Disease on Biological Agents During the SARS-CoV-2 Pandemic
por: Iborra, Ignacio, et al.
Publicado: (2021)